Orum Therapeutics, Inc. (KOSDAQ:475830)

Orum Therapeutics Statistics

Total Valuation

KOSDAQ:475830 has a market cap or net worth of KRW 1.20 trillion. The enterprise value is 1.07 trillion.

Market Cap	1.20T
Enterprise Value	1.07T

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:475830 has 21.16 million shares outstanding. The number of shares has increased by 14.29% in one year.

Current Share Class	21.16M
Shares Outstanding	21.16M
Shares Change (YoY)	+14.29%
Shares Change (QoQ)	+5.89%
Owned by Insiders (%)	16.46%
Owned by Institutions (%)	22.04%
Float	15.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	57.35
PB Ratio	7.62
P/TBV Ratio	7.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-121.53
EV / Sales	51.40
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-63.54

Financial Position

The company has a current ratio of 23.82, with a Debt / Equity ratio of 0.16.

Current Ratio	23.82
Quick Ratio	23.52
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	-1.45
Interest Coverage	-7.87

Financial Efficiency

Return on equity (ROE) is -6.45% and return on invested capital (ROIC) is -5.64%.

Return on Equity (ROE)	-6.45%
Return on Assets (ROA)	-5.50%
Return on Invested Capital (ROIC)	-5.64%
Return on Capital Employed (ROCE)	-8.19%
Revenue Per Employee	994.34M
Profits Per Employee	-420.55M
Employee Count	21
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

In the past 12 months, KOSDAQ:475830 has paid 425.37 million in taxes.

Income Tax	425.37M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	39,445.00
200-Day Moving Average	n/a
Relative Strength Index (RSI)	71.57
Average Volume (20 Days)	332,499

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:475830 had revenue of KRW 20.88 billion and -8.83 billion in losses. Loss per share was -675.12.

Revenue	20.88B
Gross Profit	20.88B
Operating Income	-14.69B
Pretax Income	-8.41B
Net Income	-8.83B
EBITDA	-11.54B
EBIT	-14.69B
Loss Per Share	-675.12

Balance Sheet

The company has 148.77 billion in cash and 24.52 billion in debt, giving a net cash position of 124.25 billion or 5,872.35 per share.

Cash & Cash Equivalents	148.77B
Total Debt	24.52B
Net Cash	124.25B
Net Cash Per Share	5,872.35
Equity (Book Value)	157.19B
Book Value Per Share	7,460.71
Working Capital	147.17B

Cash Flow

In the last 12 months, operating cash flow was -15.63 billion and capital expenditures -1.26 billion, giving a free cash flow of -16.89 billion.

Operating Cash Flow	-15.63B
Capital Expenditures	-1.26B
Free Cash Flow	-16.89B
FCF Per Share	-798.30

Margins

Gross margin is 100.00%, with operating and profit margins of -70.35% and -42.29%.

Gross Margin	100.00%
Operating Margin	-70.35%
Pretax Margin	-40.26%
Profit Margin	-42.29%
EBITDA Margin	-55.29%
EBIT Margin	-70.35%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:475830 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.29%
Shareholder Yield	-14.29%
Earnings Yield	-0.74%
FCF Yield	-1.41%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:475830 has an Altman Z-Score of 10.69 and a Piotroski F-Score of 1.

Altman Z-Score	10.69
Piotroski F-Score	1